95 related articles for article (PubMed ID: 15190262)
1. 24-hour blood pressure control: its relevance to cardiovascular outcomes and the importance of long-acting antihypertensive drugs.
Elliott HL
J Hum Hypertens; 2004 Aug; 18(8):539-43. PubMed ID: 15190262
[TBL] [Abstract][Full Text] [Related]
2. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
4. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
5. [Ambulatory blood pressure monitoring in clinical practice].
Angeli F; Reboldi G; Repaci S; Garofoli M; Casavecchia M; Ambrosio G; Verdecchia P
G Ital Cardiol (Rome); 2008 Jun; 9(6):402-7. PubMed ID: 18681391
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial.
Conen D; Tschudi P; Martina B
J Hum Hypertens; 2009 Feb; 23(2):122-9. PubMed ID: 18754021
[TBL] [Abstract][Full Text] [Related]
8. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure variability and organ damage.
Mancia G; Frattola A; Parati G; Santucciu C; Ulian L
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S6-11. PubMed ID: 7603077
[TBL] [Abstract][Full Text] [Related]
10. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M
J Hum Hypertens; 2006 Oct; 20(10):787-94. PubMed ID: 16810279
[TBL] [Abstract][Full Text] [Related]
11. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
Mancia G; Parati G; Bilo G; Maronati A; Omboni S; Baurecht H; Hennig M; Zanchetti A
J Hypertens; 2007 May; 25(5):1087-94. PubMed ID: 17414674
[TBL] [Abstract][Full Text] [Related]
12. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.
Marchesi C; Maresca AM; Solbiati F; Franzetti I; Laurita E; Nicolini E; Gianni M; Guasti L; Marnini P; Venco A; Grandi AM
Am J Hypertens; 2007 Oct; 20(10):1079-84. PubMed ID: 17903691
[TBL] [Abstract][Full Text] [Related]
13. Hypertension goals in advanced-stage kidney disease.
Hopkins K; Bakris GL
Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S92-4. PubMed ID: 19996011
[TBL] [Abstract][Full Text] [Related]
14. Choice of antihypertensive drug in the diabetic patient.
Ong HT; Cheah JS
MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
[TBL] [Abstract][Full Text] [Related]
15. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
17. [French as 2005-recommendations on the management of arterial hypertension].
Chamontin B; Halimi JM
Arch Mal Coeur Vaiss; 2007 Jan; 100(1):42-6. PubMed ID: 17405553
[TBL] [Abstract][Full Text] [Related]
18. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
19. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure variability and cardiovascular risk in treated hypertensive patients.
Pierdomenico SD; Lapenna D; Di Tommaso R; Di Carlo S; Esposito AL; Di Mascio R; Ballone E; Cuccurullo F; Mezzetti A
Am J Hypertens; 2006 Oct; 19(10):991-7. PubMed ID: 17027816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
